» Articles » PMID: 28833722

Killing Two Birds with One Stone: Response to Pembrolizumab in a Patient with Metastatic Melanoma and B-cell Chronic Lymphocytic Leukaemia

Overview
Date 2017 Aug 24
PMID 28833722
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

The impact of immune checkpoint inhibitors in patients with chronic lymphocytic leukemia (CLL): A protocol for a systematic review and meta-analysis of randomized controlled trials.

Ntsethe A, Dludla P, Nyambuya T, Ngcobo S, Nkambule B Medicine (Baltimore). 2020; 99(28):e21167.

PMID: 32664154 PMC: 7360255. DOI: 10.1097/MD.0000000000021167.


Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors.

Abdin S, Zaher D, Arafa E, Omar H Cancers (Basel). 2018; 10(2).

PMID: 29370105 PMC: 5836064. DOI: 10.3390/cancers10020032.